Quick Answer
GUIDED THERAPEUTICS INC reported Earnings Per Share Diluted of $0.04 (loss) per share for the year ending 2025.
- GUIDED THERAPEUTICS INC showed an increase of +20.0% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $0.04 (loss) per share | Fiscal year 2024: $0.05 (loss) per share | Fiscal year 2023: $0.07 (loss) per share | Fiscal year 2022: $0.15 (loss) per share | Fiscal year 2021: $0.18 (loss) per share | Fiscal year 2020: $0.04 (loss) per share | Fiscal year 2019: $0.58 (loss) per share | Fiscal year 2018: $0.01 per share | Fiscal year 2017: $0.00 per share.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: